Finally, it would be interesting to investigate whether our findings could be applied to other cancers such as head and neck squamous cell carcinoma, for example, in which TP53 mutations have an impact on survival [38], and leukemia in which missense mutations in the DNA binding domain of P53 are associated with poor survival [39]. This evidence concerns the gene TP53 and cancer.